MedPath

Oxacillin

Oxacillin for Injection, USP For Intramuscular or Intravenous Injection

Approved
Approval ID

8e99d6fe-42ab-44c1-8b51-e4ac7406dbe4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2024

Manufacturers
FDA

Armas Pharmaceuticals Inc.

DUNS: 098405973

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxacillin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72485-409
Application NumberANDA091486
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxacillin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 3, 2024
FDA Product Classification

INGREDIENTS (2)

SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74
Classification: IACT
OXACILLIN SODIUMActive
Quantity: 2 g in 1 1
Code: G0V6C994Q5
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxacillin - FDA Drug Approval Details